Cell 2006, 124: 229–231.CrossRefPubMed 23. Libbrecht L: Hepatic LY3039478 research buy progenitor cells in human liver tumor development. World J Gastroenterol

2006, 12: 6261–6265.PubMed 24. Sell S: Cellular origin of hepatocellular carcinomas. Semin Cell Dev Biol 2002, 13: 419–424.CrossRefPubMed 25. Lee JS, Heo J, Libbrecht L, Chu IS, Kaposi-Novak P, Calvisi DF, Mikaelyan A, Roberts LR, Demetris AJ, Sun Z, Nevens F, Roskams T, Thorgeirsson SS: A novel prognostic subtype of human hepatocellular carcinoma derived from hepatic progenitor cells. Nat Med 2006, 12: 410–416.CrossRefPubMed 26. Oh BK, Kim H, Park YN, Yoo JE, Choi J, Kim KS, Lee JJ, Park C: High telomerase activity and long telomeres in advanced hepatocellular carcinomas with poor prognosis. Lab Invest 2008, 88: 144–152.CrossRefPubMed 27. Sell S: The selleck role of determined stem-cells in the cellular lineage of hepatocellular carcinoma. Int J Dev Biol 1993, 37: 189–201.PubMed 28. Libbrecht L, Severi T, Cassiman D, Epoxomicin Borght S, Pirenne J, Nevens F, Verslype C, van Pelt J, Roskams T: Glypican-3 expression distinguishes

small hepatocellular carcinomas from cirrhosis, dysplastic nodules, and focal nodular hyperplasia-like nodules. Am J Surg Pathol 2006, 30: 1405–1411.CrossRefPubMed 29. Kitao S, Yamada T, Ishikawa T, Madarame H, Furuichi M, Neo S, Tsuchiya R, Kobayashi K: Alpha-fetoprotein in serum and tumor tissues in dogs with hepatocellular carcinoma. J Vet Diagn Invest 2006, 18: 291–295.PubMed 30. Bruix J, Sherman M, Llovet JM, Beaugrand M, Lencioni R, Burroughs AK, Christensen E, Pagliaro L, Colombo M, Rodes J: Clinical management Alectinib in vitro of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association

for the Study of the Liver. J Hepatol 2001, 35: 421–430.CrossRefPubMed 31. Ding SJ, Li Y, Tan YX, Jiang MR, Tian B, Liu YK, Shao XX, Ye SL, Wu JR, Zeng R, et al.: From proteomic analysis to clinical significance: overexpression of cytokeratin 19 correlates with hepatocellular carcinoma metastasis. Mol Cell Proteomics 2004, 3: 73–81.PubMed 32. Dobashi N, Fujita J, Murota M, Ohtsuki Y, Bandoh S, Ueda Y, Dohmoto K, Hojo S, Nishioka M, Ishida T, Takahara J: Binding of recombinant human cytokeratin 19 to laminin: a possible role in interaction between intermediate filament derived from epithelial cells and extracellular matrixes. Cell Struct Funct 2000, 25: 171–175.CrossRefPubMed 33. Chu YW, Runyan RB, Oshima RG, Hendrix MJ: Expression of complete keratin filaments in mouse L cells augments cell migration and invasion. Proc Natl Acad Sci USA 1993, 90: 4261–4265.CrossRefPubMed 34. Uenishi T, Kubo S, Hirohashi K, Tanaka H, Shuto T, Yamamoto T, Nishiguchi S: Cytokeratin-19 fragments in serum (CYFRA 21–1) as a marker in primary liver cancer. Br J Cancer 2003, 88: 1894–1899.CrossRefPubMed 35.